When do carcinogen-treated 10T1/2 cells acquire the commitment to form transformed foci?

J M Backer, M Boerzig, I B Weinstein

Nature

|September 30, 1982

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Stat3 orchestrates tumor development and progression: the Achilles' heel of head and neck cancers?

Current cancer drug targets·2010

Activated checkpoint kinase 2 expression and risk for oral squamous cell carcinoma.

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology·2007

Hint1 is a haplo-insufficient tumor suppressor in mice.

Oncogene·2005

Roles of cyclin D1 and related genes in growth inhibition, senescence and apoptosis.

Apoptosis : an international journal on programmed cell death·2003

Cyclin D1 overexpression is more prevalent in non-Caucasian breast cancer.

Anticancer research·2002

Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines.

Clinical cancer research : an official journal of the American Association for Cancer Research·2001

See all related articles

Related Experiment Videos

When do carcinogen-treated 10T1/2 cells acquire the commitment to form transformed foci?

Related Concept Videos

Related Articles